TRANSFORMER: Bipolar androgen therapy (BAT) versus enzalutamide (E) for castration-resistant metastatic prostate cancer (mCRPC).
暂无分享，去创建一个
David C. Smith | N. Agarwal | E. Antonarakis | V. Bolejack | M. Carducci | M. Schweizer | T. Flaig | J. Holzbeierlein | M. Eisenberger | S. Denmeade | C. Paller | M. Markowski | M. Stein | Hao Wang | V. Assikis | W. Fu | R. Szmulewitz | Ting Wang | H. Cao | Rehab Abdallah